Showing results (201-210 of 4,494) with videos related to
Sort By:
Pageof 450
Advances in Therapy|April 12, 2020
Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year ResultsClaudia Taipale, Juha-Matti Lindholm, Kai Kaarniranta, et al.Advances in Therapy|October 26, 2019
Comparison of Excimer Laser Versus Femtosecond Laser Assisted Trephination in Penetrating Keratoplasty: A Retrospective StudyGábor Tóth, Nóra Szentmáry, Achim Langenbucher, et al.Advances in Therapy|October 27, 2019
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid ArthritisRoberta Gualtierotti, Francesca Ingegnoli, Massimo Boscolo, et al.Advances in Therapy|October 27, 2019
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to PatientsLuigino Calzetta, Maria Gabriella Matera, Mario Cazzola, et al.Advances in Therapy|April 16, 2020
Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of ProbioticsMartina Rekatsina, Antonella Paladini, Maria Grazia Cifone, et al.Advances in Therapy|April 17, 2020
Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-AnalysisJanet Pope, Ruta Sawant, Namita Tundia, et al.Advances in Therapy|April 23, 2020
Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative ReviewVincent Martin, Karen Hamrick Samaan, Sheena Aurora, et al.Advances in Therapy|June 20, 2020
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort StudySung-Ji Park, Si Jae RheeAdvances in Therapy|May 5, 2020
A Novel Nomogram Integrated with Inflammation-Based Factors to Predict the Prognosis of Gastric Cancer PatientsXueping Wang, Minjie Mao, Shihao Zhu, et al.Advances in Therapy|April 20, 2020
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UKPierre Johansen, Barrie Chubb, Barnaby Hunt, et al.Pageof 450